首页> European journal of nuclear medicine and molecular imaging> The utility of [<sup>18</sup>F]FDG PET in discriminating between local recurrence and inflammatory changes following SABR in primary lung cancer patients.

The utility of [<sup>18</sup>F]FDG PET in discriminating between local recurrence and inflammatory changes following SABR in primary lung cancer patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maria,Fala

第一单位： Royal Free London NHS Foundation Trust, London, UK. Mariatfala@gmail.com.

作者： Maria,Fala ^[1] ; Eleni,Josephides ^[2] ; Sweni,Shah ^[3] ; Hemal,Ariyaratne ^[4] ; Anant,Patel ^[4] ; Gary J R,Cook ^[5] ; Sugama,Chicklore ^[6] ; Thomas,Wagner ^[7]

作者单位： Royal Free London NHS Foundation Trust, London, UK. Mariatfala@gmail.com. ^[1] Guy's and St Thomas' NHS Foundation Trust, London, UK. ^[2] Royal Free London NHS Foundation Trust, London, UK.;East & North Hertfordshire NHS Trust, Stevenage, UK. ^[3] Royal Free London NHS Foundation Trust, London, UK. ^[4] King's College London & Guy's and St. Thomas' PET Centre, St Thomas' Hospital, London, UK. ^[5] King's College London & Guy's and St. Thomas' PET Centre, St Thomas' Hospital, London, UK.;School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK. ^[6] Royal Free London NHS Foundation Trust, London, UK.;Centre for Medical Imaging, Department of Imaging, University College London, London, UK. ^[7]

关键词 18F-FDG PET-CT Lung cancer Recurrence SABR